Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

12 results
Display

Antihypertensive effect of perindopril in patients with essential hypertension

Cho HG, Kang DH, Kim HS, Ha SK, Lee HY, Han DS

  • KMID: 1694616
  • Korean J Nephrol.
  • 1993 Mar;12(1):76-83.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Hypotensive Effect of Perindopril in Patients with Essential Hypertension

Bae JH, Kang HS, Kim KS, Kim MS, Song JS

To evaluate the effect of Perindopril in patients with essential hypertension, we administered Perindopril 4 to 8mg/day once daily to 30 patients(18 males, 12 females) for 12 weeks. Baseline blood...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Antihypertensive Efficacy and Safety of Perindopril Versus Nifedipine in High Salt Intake Essential Hypertensives : A Double-Blind Parallel Group Study

Kim DW, Seo JD, Cho SW, Hyon MS, Shon DW, Oh BH, Lee MM, Park YB, Choi YS, Lee YW

BACKGROUND: To assess the efficacy and safety of perindopril, a new angiotensin-converting enzyme(ACE) inhibitor, perindopril was compaired to nifedipine LP. METHODS: Perindopril(4mg q.d.) was compaired to nifedipine LP(20mg b.i.d.) in the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Clinical Study on the Antihypertensive Effect, and the Changes of Left Ventricular Mass and Left Ventricular Diastolic Function of Perindopril

Jung WS, Park JW, Youn HJ, Lee MY, Park JC, Chae JS, Kim JH, Choi KB, Hong SJ

BACKGROUND: Perindopril, a new second-generation angiotensin converting enzyme inhinbitor was administered in essential hypertensive patients in order to observe the clinical effects. METHOD: The changes of blood pressure. heart rate, clinical...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Clinical Effects of Perindopril(Acertil(R)) on Hypertensive Patients

Jeong MH, Suh JP, Lee MK, Park JS, Ahn YK, Park JH, Jeong EA, Cho JG, Park JC, Kang JC, Park YG, Kang YJ

BACKGROUND: Perindopril. a new second-generation angiotensin converting enzyme inhibitor developed by Servier Research, was administered in essential hypertensive patients in order to observe the clinical effects. METHOD: The changes of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Clinical Couse and Echocardiographic Findings of Long-Term Angiotensin Converting Enzyme Inhibitor Therapy in the Patients with Severe Chronic Congestive Heart Failure

Son JW, Bae SM, Kam DH, Kim KD, Dho HK, Kim MH, Kim JS

BACKGROUND: Congestive heart failure is a serious and growing clinical problem. Diuretics and digitalis glycosides remain the traditional regimens of therapy in patients with congestive heart failure, however, angiotensin coverting...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Pleural Effusion and Pulmonary Edema Caused by Calcium Channel Blockers in a Patient of Systemic Hypertension

Kim DK, Kim JS, Yi HR, Choi IZ, Ahn HS, Cho WH

Calcium channel blockers (CCBs) are very popular drugs to lower blood pressure (BP) without significant side effects. A 72-year-old man admitted for uncontrolled hypertension. He had history of hypertension, atrial...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effects of Angiotensin-Converting Enzyme Inhibitor on Arterial Stiffness, Diastolic Function, and Exercise Performance in Patients with Hypertension

Kim KH, Park JC, Oh CS, Choi SH, Kim MR, Lee WS, Yoon HJ, Ahn Y, Jeong MH, Cho JG, Kang JC

BACKGROUND: The aim of this study was to investigate the relations between arterial stiffness, diastolic function, and exercise performance and the effects of angiotensin-converting enzyme inhibitor(ACEI), perindopril, in these three...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Clinical Study of Amosulalol Hydrochloride(YM-09538) on the Antihypertensive Effects in Essential Hypertension

Lee DI, Moon CH, Hwang SY, Kim BW, Lee JG, Shin YK

BACKGROUND: Newly developed alpha-, beta-receptor blocker, Amosulalol HCI(YM-09538) was evaluated for its hypotensive efficacy, safety and usefulness in patients with mild to moderate essential hypertension. METHODS: Thirty patients of essential hypertension(male...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Risk factors of Angiotensin-Converting Enzyme Inhibitor-Induced Cough in Patients with Hypertension

Na SH, Lee JH, Lee HY, Lee SY, Kim HS, Chae IH, Sohn DW, Oh BH, Lee MM, Park YB, Choi YS, Lee YW

BACKGROUND AND OBJECTIVES: The reported incidence of angiotensin converting enzyme inhibitor-induced cough ranges widely from 1.3% to 44% in many studies, depending upon methods of data collection, analysis, symptom reporting,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Cardioprotective Effect of Fimasartan, a New Angiotensin Receptor Blocker, in a Porcine Model of Acute Myocardial Infarction

Sim DS, Jeong MH, Song HC, Kim J, Chong A, Bom HS, Jeong IS, Oh SG, Kim JM, Park DS, Kim JH, Lim KS, Kim MS, Ryu SH, Kim HK, Kim SS, Jang SY, Cho JY, Jeong HC, Lee KH, Park KH, Yoon NS, Yoon HJ, Kim KH, Hong YJ, Park HW, Kim JH, Ahn Y, Cho JG, Park JC, Kang JC

Cardioprotective effect of fimasartan, a new angiotensin receptor blocker (ARB), was evaluated in a porcine model of acute myocardial infarction (MI). Fifty swine were randomized to group 1 (sham, n=10),...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Regulation of Glucose Control in People with Type 2 Diabetes: A Review and Consensus

Woo JT, Park KS, Byun DW, Ko KS, Chung YS, Kim DM, Park TS, Cha BS, Lee IK, Park JY, Son HS, Lee MK, Kim KW, Son HY

A conference was convened by the Korean Diabetes Association and the Korean Endocrine Society on September 7, 2009 to discuss and organize the results of research on intensive glucose control...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr